GOVX / GeoVax: A Legitimate COVID-19 Phase 2 Vaccine Candidate Trading At Only A $25 Million Valuation

GeoVax to Host Second Quarter 2023 Conference Call at 4:30 PM ET ATLANTA, GA, July 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc more_horizontal

GeoVax Labs, Inc. (NASDAQ:GOVX ) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Gabby DeGravina - Investor Relations Dav more_horizontal

GeoVax Labs, Inc. (NASDAQ:GOVX ) Q4 2022 Earnings Conference Call March 23, 2023 4:30 PM ET Company Participants Gabrielle DeGravina - CG Capital Davi more_horizontal

Shares of GeoVax (NASDAQ: GOVX ) are shooting to the top of today's trending ticker list. That's as GOVX stock is higher by about 60% so far on Wednes more_horizontal

GeoVax Labs, Inc. (NASDAQ:GOVX ) Q3 2022 Earnings Conference Call November 9, 2022 4:30 PM ET Company Participants Gabrielle DeGravina - CG Capital Da more_horizontal

Use these strategies for investing in penny stocks in 2022 The post How to Find Penny Stocks to Buy This Month, 3 Tips appeared first on Penny Stocks more_horizontal

GeoVax has multiple routes to go in terms of Covid-19 vaccine development; use of GEO-CM04S1 for Covid-19 in immunocompromised patients and as booster more_horizontal

The monkeypox outbreak has affected 780 people since identified on May 13, 2022. Vaccines are key to curtailing the spread of Monekey Pox. Two pharma more_horizontal